(OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, unveiled a potential game-changer in the fight against ...

22, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, fibrosis, stroke, ...

(RTTNews) - Bioxytran Inc. (BIXT), Wednesday announced the development of a groundbreaking treatment to combat Highly Pathogenic Avian Influenza or HPAI, also known as Bird Flu, in egg-laying ...